학술논문
Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial
Document Type
Article
Author
Rescigno, P.; Porta, N.; Finneran, L.; Riisnaes, R.; Figueiredo, I.; Carreira, S.; Flohr, P.; Miranda, S.; Bertan, C.; Ferreira, A.; Crespo, M.; Rodrigues, D.N.; Gurel, B.; Espinasse, A.; Hall, E.; de Bono, J.; Nobes, J.; Crabb, S.; Malik, Z.; Ralph, C.; McGovern, U.; Hoskin, P.; Jones, R.J.; Birtle, A.; Gale, J.; Sankey, P.; Jain, S.; McLaren, D.; Chadwick, E.
Source
In: European Journal of Cancer . (European Journal of Cancer, July 2024, 205)
Subject
Language
English
ISSN
18790852
09598049
09598049